| Website | signosticsmedical... |
| Category | BioTech |
| Phone | 650.327.4000 |
| ccooper@signostic... | |
| Employees | |
| Founded | 2005 |
| Description | handheld ultrasound product |
| TOTAL | $9M |
| FUNDING TOTAL | $9M |
| Series A, 9/09 Brandon Capital Partners Playford Capital Terra Rossa Capital | $4M |
| Series B, 4/10 Brandon Capital Partners Playford Capital Terra Rossa Capital | $5M |
Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it is anticipated the Signos will change the way healthcare professionals practice medicine.
Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable pointâ€ofâ€care medical devices. The company launched its first product into the veterinarian market in January 2009 and gained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
